Publication Name	World Journal of Diabetes
Manuscript ID	31041
Country	India

Received	2016-10-27 21:16
Peer-Review Started	2016-10-31 15:28
To Make the First Decision	2016-12-01 14:31
Return for Revision	2016-12-05 13:34
Revised	2017-02-09 17:36
Second Decision	2017-03-15 17:24
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-04-24 10:21
Articles in Press	2017-04-24 10:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-06-26 01:20
Publish the Manuscript Online	2017-07-03 04:05

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Randomized Controlled Trial
Article Title	Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus - defining adequate administration methods
Manuscript Source	Invited Manuscript
All Author List	Vikas Sood, Anil Bhansali, Bhagwant Rai Mittal, Baljinder Singh, Neelam Marwaha, Ashish Jain and Niranjan Khandelwal
Funding Agency and Grant Number
Corresponding Author	Vikas Sood, MBBS, DRM, PhD, Assistant Professor, 2nd Nuclear Medicine Centre, Indira Gandhi Medical College, Circular Road, Shimla 171001, India. vikasvineeta@rediffmail.com
Key Words	Autologous bone marrow derived stem cell therapy; Type 2 diabetes mellitus
Core Tip	Homing of stem cells to pancreas is an important pre-requisite for achieving therapeutic efficacy in type 2 diabetes mellitus patients. Homing of stem cells was demonstrated when targeted infusion was carried out. No discernible homing was there when intravenous infusion route was employed. It was only in the targeted group that a 50% reduction in Insulin dosage was observed, establishing a relationship between homing and therapeutic efficacy.
Publish Date	2017-07-03 04:05
Citation	Sood V, Bhansali A, Mittal BR, Singh B, Marwaha N, Jain A, Khandelwal N. Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus - defining adequate administration methods. World J Diabetes 2017; 8(7): 381-389
URL	http://www.wjgnet.com/1948-9358/full/v8/i7/381.htm
DOI	http://dx.doi.org/10.4239/wjd.v8.i7.381

Full Article (PDF)	WJD-8-381.pdf
Full Article (Word)	WJD-8-381.doc
Manuscript File	31041-Review.docx
Answering Reviewers	31041-Answering reviewers.pdf
Audio Core Tip	31041-Audio core tip.wma
Biostatistics Review Certificate	31041-Biostatistics statement.pdf
Clinical Trial Registration Statement	31041-Clinical trial registration statement.PDF
Conflict-of-Interest Disclosure Form	31041-Conflict-of-interest statement.pdf
Copyright License Agreement	31041-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	31041-Informed consent statement.PDF
Institutional Review Board Approval Form or Document	31041-Institutional review board statement.PDF
Non-Native Speakers of English Editing Certificate	31041-Language certificate.pdf
Peer-review Report	31041-Peer-review(s).pdf
Scientific Misconduct Check	31041-Scientific misconduct check.pdf
Scientific Editor Work List	31041-Scientific editor work list.pdf